| Xenobiotic metabolism and gut microbiomes A Das, M Srinivasan, TS Ghosh, SS Mande PloS one 11 (10), e0163099, 2016 | 74 | 2016 |
| Comparison of various severity assessment scoring systems in patients with sepsis in a tertiary care teaching hospital K Badrinath, M Shekhar, M Sreelakshmi, M Srinivasan, G Thunga, S Nair, ... Indian journal of critical care medicine: peer-reviewed, official …, 2018 | 31 | 2018 |
| Diversity in the era of precision medicine-from bench to bedside implementation A Mamun, NY Nsiah, M Srinivasan, A Chaturvedula, R Basha, D Cross, ... Ethnicity & disease 29 (3), 517, 2019 | 16 | 2019 |
| Incorporating pharmacometrics into pharmacoeconomic models: applications from drug development M Srinivasan, A White, A Chaturvedula, V Vozmediano, S Schmidt, ... Pharmacoeconomics 38, 1031-1042, 2020 | 14 | 2020 |
| Pharmacokinetic potentiation of mixed organophosphate and pyrethroid poison leading to prolonged delayed neuropathy M Srinivasan, R Amin, G Thunga, SK Nagiri, CU Kudru Journal of clinical and diagnostic research: JCDR 10 (11), FD01, 2016 | 12 | 2016 |
| Comparison of the Nosocomial Pneumonia Mortality Prediction (NPMP) model with standard mortality prediction tools M Srinivasan, N Shetty, S Gadekari, G Thunga, K Rao, V Kunhikatta Journal of Hospital Infection 96 (3), 250-255, 2017 | 9 | 2017 |
| Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects C Tiffany, EF Dumont, M Hossain, M Srinivasan, B Swift Clinical and Translational Science 15 (9), 2251-2264, 2022 | 6 | 2022 |
| Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs S Anderson, J Mauskopf, SE Talbird, A White, M Srinivasan Epilepsy & Behavior 125, 108368, 2021 | 6 | 2021 |
| Development of a pharmacoeconomic registry: an example using hormonal contraceptives A White, M Srinivasan, LM Wingate, S Peasah, M Fleming Health Economics Review 11, 1-20, 2021 | 5 | 2021 |
| The Nosocomial Pneumonia Mortality Prediction (NPMP) model–a tool to predict mortality in patients with nosocomial pneumonia V Kunhikatta, M Srinivasan, G Thunga, NR Rau, AN Nagappa Indian Journal of Medical Specialities 8 (1), 21-24, 2017 | 4 | 2017 |
| Utility of Physiologically Based Pharmacokinetic Modeling in Point-of-Care Decisions: An Example Using Digoxin Dosing in Continuous Venovenous Hemodiafiltration M Srinivasan, R Hirani, M Tsiu, K Kabani, A Chaturvedula, B Palasik Therapeutic Drug Monitoring 42 (1), 1-5, 2020 | 3 | 2020 |
| Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters A Barth, CR Perry, S Shabbir, MJ Zamek‐Gliszczynski, S Thomas, ... Clinical and Translational Science 16 (4), 647-661, 2023 | 2 | 2023 |
| Pharmacokinetic, safety, and tolerability evaluations of gepotidacin (GSK2140944) in healthy Japanese participants A Barth, M Hossain, CR Perry, AS Gross, H Ogura, S Shabbir, S Thomas, ... Clinical Pharmacology in Drug Development 12 (1), 38-56, 2023 | 2 | 2023 |
| Population Pharmacokinetics of Pemetrexed in Adult Non–Small Cell Lung Cancer in Indian Patients M Srinivasan, A Chaturvedula, MJ Fossler, A Patil, V Gota, K Prabhash The Journal of Clinical Pharmacology 59 (9), 1216-1224, 2019 | 2 | 2019 |
| Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian Patients VG Meenakshi Srinivasan, Ayyappa Chaturvedula, Michael J. Fossler, Anand ... Ninth American Conference on Pharmacometrics (ACoP9), 45 (S1), https://link …, 2018 | 2* | 2018 |
| Identification of potential risk factors for the poor prognosis of neonatal sepsis P Sahu, M Srinivasan, G Thunga, LE Lewis, V Kunhikatta Medicine and Pharmacy Reports 95 (3), 282, 2022 | 1 | 2022 |
| Outcomes and economic burden of hormonal contraceptive failure in developing countries: A case for improving effectiveness? M Srinivasan, A White | 1 | 2019 |
| Evaluation of the Sensitivity of Concluding Bioequivalence Using Stochastic Simulation and Estimation K Fairman, A Chaturvedula, M Srinivasan | 1 | 2018 |
| PIH9 BUDGET IMPACT ANALYSIS VS. COST EFFECTIVENESS ANALYSIS-HORMONAL CONTRACEPTIVES AS AN ILLUSTRATIVE CASE JDK Nzia, A White, M Srinivasan Value in Health 23, S152, 2020 | | 2020 |
| PIH13 COST IMPLICATIONS OF DRUG-DRUG INTERACTIONS WITH HORMONAL CONTRACEPTIVES: A CONCEPTUAL FRAMEWORK BASED ON LINKED PHARMACOKINETIC-PHARMACODYNAMIC-PHARMACOECONOMIC (PK-PD … M Srinivasan, A White, A Chaturvedula, S Schmidt, G Adunlin, LT Wingate Value in Health 22, S184-S185, 2019 | | 2019 |
